Effects of N-phenylpropyl-N'-substituted piperazine sigma receptor ligands on cocaine-induced hyperactivity in mice

Pharmacology Biochemistry and Behavior

Volumn 110, Issue , 2013, Pages 201-207

  Sage, Andrew S ^a   Oelrichs, Clark E ^a   Davis, Derick C ^a   Fan, Kuo Hsien ^a   Nahas, Roger I ^a   Lever, Susan Z ^a   Lever, John R ^b,c   Miller, Dennis K ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Behavior; Cocaine; Locomotor activity; Mouse; Sigma receptor

Indexed keywords

ANTICONVULSIVE AGENT; COCAINE; CUTAMESINE; N PHENYLPROPYL N' (4 METHOXYPHENETHYL)PIPERAZINE; N PHENYLPROPYL N' (4METHOXYBENZYL)PIPERAZINE; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG; YZ 067; YZ 185;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; DRUG MEGADOSE; DRUG STRUCTURE; FOLLOW UP; HYPERACTIVITY; LOCOMOTION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION;

MUS;

BEHAVIOR; COCAINE; LOCOMOTOR ACTIVITY; MOUSE; SIGMA RECEPTOR;

ANIMALS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERKINESIS; LIGANDS; MALE; MICE; PIPERAZINES; RECEPTORS, SIGMA;

EID: 84881135106     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.07.006     Document Type: Article

References (27)

1. Cobos EJ, Entrena JM, Nieto FR, Cendan CM, Del PE. Pharmacology and therapeutic potential of sigma1 receptor ligands. Curr Neuropharmacol 2008;6: 344-66.
2. Fujimoto M, Hayashi T, Urfer R, Mita S, Su TP. Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor. Synapse 2012;66: 630-9.
3. Hall FS, Li XF, Randall-Thompson J, Sora I,Murphy DL, Lesch KP, et al. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. Neuroscience 2009;162: 870-80.
4. Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival. Cell 2007;131: 596-610. (Pubitemid 350017760)
5. Hayashi T, Justinova Z, Hayashi E, Cormaci G, Mori T, Tsai SY, et al. Regulation of σ-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats. J Pharmacol Exp Ther 2010;332: 1054-63.
6. Ishikawa M, Hashimoto K. The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases. J Recept Ligand Channel Res 2010;3: 25-36.
7. Katz JL, Su TP, Hiranita T, Hayashi T, Tanda G, Kopajtic T, et al. A role for sigma receptors in stimulant self administration and addiction. Pharmaceuticals (Basel) 2011;4: 880-914.
8. Kourrich S, Hayashi T, Chuang JY, Tsai SY, Su TP, Bonci A. Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 2013;152: 236-47.
9. Kuhar MJ, Ritz MC, Boja JW. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 1991;14: 299-302.
10. Kurokawa K, Mizuno K, Shibasaki M, Ohkuma S. Regulation of type 1 inositol 1,4,5- triphosphate receptor by dopamine receptors in cocaine-induced place conditioning. Synapse 2012;66: 180-6.
11. Lever JR, Gustafson JL, Xu R, Allmon RL, Lever SZ. Sigma-1 and sigma-2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503. Synapse 2006;59: 350-8.
12. Matsumoto RR, McCracken KA, Pouw B, Zhang Y, Bowen WD. Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides. Neuropharmacology 2002;42: 1043-55. (Pubitemid 34786557)
13. Matsumoto RR, Liu Y, Lerner M, Howard EW, Brackett DJ. σ Receptors: potential medications development target for anti-cocaine agents. Eur J Pharmacol 2003;469: 1-12. (Pubitemid 36629544)
14. Matsumoto RR, Potelleret FH, Mack A, Pouw B, Zhang Y, Bowen WD. Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies. Pharmacol Biochem Behav 2004;77: 775-81. (Pubitemid 38510289)
15. McCracken KA, Bowen WD, de Costa BR, Matsumoto RR. Two novel σ receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity. Eur J Pharmacol 1999;370: 225-32. (Pubitemid 29192866)
16. Menkel M, Terry P, Pontecorvo M, Katz JL, Witkin JM. Selective sigma ligands block stimulant effects of cocaine. Eur J Pharmacol 1991;201: 251-2.
17. Morice E, Denis C, Giros B, Nosten-Bertrand M. Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice. Psychopharmacology 2010;208: 57-66.
18. Nahas RI, Lever JR, Lever SZ. Synthesis and structure-activity relationships of N-(3- phenylpropyl)-N'-benzylpiperazines: potent ligands for σ1 and σ2 receptors. Bioorg Med Chem 2008;16: 755-61. (Pubitemid 351163058)
19. Patel JC, Witkovsky P, Avshalumov MV, Rice ME. Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release. J Neurosci 2009;29: 6568-79.
20. Rodvelt KR, Lever SZ, Lever JR, Blount LR, Fan KH, Miller DK. SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus. Pharmacol Biochem Behav 2011a;97: 676-82.
21. Rodvelt KR, Oelrichs CE, Blount LR, Fan KH, Lever SZ, Lever JR, et al. The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine. Drug Alcohol Depend 2011b;116: 203-10.
22. Sharkey J, Glen KA, Wolfe S, Kuhar MJ. Cocaine binding at σ receptors. Eur J Pharmacol 1988;149: 171-4.
23. Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG. Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter. CNS Neurol Disord Drug Targets 2006;5: 45-56. (Pubitemid 43796627)
24. Su TP, Hayashi T, Maurice T, Buch S, Ruoho AE. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol Sci 2010;31: 557-66.
25. Trinh JV, Nehrenberg DL, Jacobsen JP, Caron MG,WetselWC. Differential psychostimulantinduced activation of neural circuits in dopamine transporter knockout and wild type mice. Neuroscience 2003;118: 297-310. (Pubitemid 36423245)
26. Uhl GR, Hall FS, Sora I. Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 2002;7: 21-6. (Pubitemid 34087875)
27. Walker JM, Bowen WD, Walker FO, Matsumoto RR, De CB, Rice KC. Sigma receptors: biology and function. Pharmacol Rev 1990;42: 355-402.